S. 637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
- Sponsor:
- Ron Wyden
- Summary:
- A bill to amend titles XI and XVIII of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers. (by CRS)
- Status:
- The bill has been referred to committee.
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
S. 637 — 115th Congress (2017–2018)
- Summary
- A bill to amend titles XI and XVIII of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to amend titles XI and XVIII of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers.
- Other Titles
- Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
- Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
- Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
- Sponsor
- Ron Wyden
- Co-Sponsors
- Subjects
- Health
- Government information and archives
- Health care costs and insurance
- Inflation and prices
- Medicare
- Prescription drugs
- Related Bills
- Major Actions
Introduced 3/15/2017 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 3/15/2017 3/15/2017 Introduced in Senate 3/15/2017 Read twice and referred to the Committee on Finance. Number Sponsor Date Offered Status
Average contributions given to Senators from interest groups that…
support this bill
Other physician specialists |
Health, Education & Human Resources |
Nurses |
Health & welfare policy |
Pharmacists |
Health professionals |
oppose this bill
Pharmaceutical manufacturing |
Fiscal & tax policy |
Contributions data source: OpenSecrets.org